RNAs as Candidate Diagnostic and Prognostic Markers of Prostate Cancer—From Cell Line Models to Liquid Biopsies

The treatment landscape of prostate cancer has evolved rapidly over the past five years. The explosion in treatment advances has been witnessed in parallel with significant progress in the field of molecular biomarkers. The advent of next-generation sequencing has enabled the molecular profiling of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Marvin C. J., Baird, Anne-Marie, Aird, John, Greene, John, Kapoor, Dhruv, Gray, Steven G., McDermott, Ray, Finn, Stephen P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163368/
https://www.ncbi.nlm.nih.gov/pubmed/30200254
http://dx.doi.org/10.3390/diagnostics8030060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163368/
https://www.ncbi.nlm.nih.gov/pubmed/30200254
http://dx.doi.org/10.3390/diagnostics8030060

Ejemplares similares